Bausch Health Companies — Barclays Global Healthcare Conference 2018

5 slides from Bausch Health Companies's conference presentation, Mar 14, 2018

Slide 1: Barclays Global Healthcare Conference
Barclays Global Healthcare Conference March 14, 2018
Slide 2: Forward-Looking Statements
Forward-Looking Statements Forward-Looking Statements time in the Company's other filings with the Securities and This presentation contains forward-looking information and Exchange Commission and the Canadian Securities statements, within the meaning of applicable securities laws Administrators, wh
Slide 3: Successful Execution Against 2018 Plan
Successful Execution Against 2018 Plan Execution to date demonstrates the returning strength of the business and upward trends expected for the remainder of the year. XIFAXAN® Highlights RAM06 Launch • 2017 Highlights: Organic revenue growth1 of 5% in • Growth in 2018 reflects synergies in the RAM f
Slide 4: Successful Execution Against 2018 Plan
Successful Execution Against 2018 Plan APRISO® TRx +9% in First Nine Weeks RELISTOR® TRx +46% in First Nine Weeks of 2018 vs. First Nine Weeks of 20171 of 2018 vs. First Nine Weeks of 20171 12,500 1,600 1,500 12,000 1,400 1,311 11,455 1,300 11,500 Christmas 1,200 Thanksgiving 11,000 1,100 10,847 1,0
Slide 5: Successful Execution Against 2018 Plan
Successful Execution Against 2018 Plan MIGRANAL®/MIGRANAL® AG Monthly TRx +38% in Jan. 2018 vs. Jan. 20171,2,3 4,800 4,300 3,974 3,800 3,300 2,882 2,800 2,300 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2016 2017 2018 5 1. NPA Audit from February 2012 to January 2018. 2. NPA Weekly Audit from Fe